NasdaqGS - Nasdaq Real Time Price USD
Milestone Pharmaceuticals Inc. (MIST)
At close: November 6 at 4:00 PM EST
After hours: 7:46 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-36,943.0000
-46,424.0000
-52,469.0000
-33,224.0000
-50,732.0000
Investing Cash Flow
-14,713.0000
4,756.0000
-57,124.0000
70,000.0000
-70,000.0000
Financing Cash Flow
32,327.0000
47,792.0000
3,088.0000
5,055.0000
73,224.0000
End Cash Position
13,262.0000
13,760.0000
7,636.0000
114,141.0000
72,310.0000
Capital Expenditure
-56.0000
-112.0000
-272.0000
--
--
Issuance of Capital Stock
27,258.0000
--
2,630.0000
--
24,917.0000
Issuance of Debt
--
50,000.0000
--
--
--
Free Cash Flow
-36,999.0000
-46,536.0000
-52,741.0000
-33,224.0000
-50,732.0000
12/31/2020 - 5/9/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATRA Atara Biotherapeutics, Inc.
10.01
-2.68%
SCPH scPharmaceuticals Inc.
4.3400
+6.63%
EYEN Eyenovia, Inc.
0.5002
-1.50%
ATYR aTyr Pharma, Inc.
3.2500
+3.17%
SGMT Sagimet Biosciences Inc.
6.00
+3.27%
VRCA Verrica Pharmaceuticals Inc.
0.7463
-6.42%
UNCY Unicycive Therapeutics, Inc.
0.5020
+1.46%
CKPT Checkpoint Therapeutics, Inc.
3.3700
+2.12%
RAPT RAPT Therapeutics, Inc.
2.7200
+11.02%
VINC Vincerx Pharma, Inc.
0.3270
-5.49%